Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study
The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogene...
Saved in:
Published in | BMC cancer Vol. 7; no. 1; p. 97 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
08.06.2007
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogenesis. Therefore we have examined the activation of Akt in Barrett's oesophagus and oesophageal adenocarcinoma and the functional effects of Akt activation in vitro.
Expression of total and active (phosphorylated) Akt were determined in endoscopic biopsies and surgical resection specimens using immunohistochemistry. The functional effects of Akt were examined using Barrett's adenocarcinoma cells in culture.
In normal squamous oesophagus, erosive oesophagitis and non-dysplastic Barrett's oesophagus, phospho-Akt was limited to the basal 1/3 of the mucosa. Image analysis confirmed that Akt activation was significantly increased in non-dysplastic Barrett's oesophagus compared to squamous epithelium and further significantly increased in high-grade dysplasia and adenocarcinoma. In all cases of high grade dysplasia and adenocarcinoma Akt was activated in the luminal 1/3 of the epithelium. Transient acid exposure and the obesity hormone leptin activated Akt, stimulated proliferation and inhibited apoptosis: the combination of acid and leptin was synergistic. Inhibition of Akt phosphorylation with LY294002 increased apoptosis and blocked the effects of acid and leptin both alone and in combination. Activation of Akt was associated with downstream phosphorylation and deactivation of the pro-apoptotic protein Bad and phosphorylation of the Forkhead family transcription factor FOXO1.
Akt is abnormally activated in Barrett's oesophagus, high grade dysplasia and adenocarcinoma. Akt activation promotes proliferation and inhibits apoptosis in Barrett's adenocarcinoma cells and both transient acid exposure and leptin stimulate Akt phosphorylation. Downstream targets of Akt include Bad and Forkhead transcription factors. Activation of Akt in obesity and by reflux of gastric acid may be important in the pathogenesis of Barrett's adenocarcinoma. |
---|---|
AbstractList | The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogenesis. Therefore we have examined the activation of Akt in Barrett's oesophagus and oesophageal adenocarcinoma and the functional effects of Akt activation in vitro.
Expression of total and active (phosphorylated) Akt were determined in endoscopic biopsies and surgical resection specimens using immunohistochemistry. The functional effects of Akt were examined using Barrett's adenocarcinoma cells in culture.
In normal squamous oesophagus, erosive oesophagitis and non-dysplastic Barrett's oesophagus, phospho-Akt was limited to the basal 1/3 of the mucosa. Image analysis confirmed that Akt activation was significantly increased in non-dysplastic Barrett's oesophagus compared to squamous epithelium and further significantly increased in high-grade dysplasia and adenocarcinoma. In all cases of high grade dysplasia and adenocarcinoma Akt was activated in the luminal 1/3 of the epithelium. Transient acid exposure and the obesity hormone leptin activated Akt, stimulated proliferation and inhibited apoptosis: the combination of acid and leptin was synergistic. Inhibition of Akt phosphorylation with LY294002 increased apoptosis and blocked the effects of acid and leptin both alone and in combination. Activation of Akt was associated with downstream phosphorylation and deactivation of the pro-apoptotic protein Bad and phosphorylation of the Forkhead family transcription factor FOXO1.
Akt is abnormally activated in Barrett's oesophagus, high grade dysplasia and adenocarcinoma. Akt activation promotes proliferation and inhibits apoptosis in Barrett's adenocarcinoma cells and both transient acid exposure and leptin stimulate Akt phosphorylation. Downstream targets of Akt include Bad and Forkhead transcription factors. Activation of Akt in obesity and by reflux of gastric acid may be important in the pathogenesis of Barrett's adenocarcinoma. BACKGROUND: The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogenesis. Therefore we have examined the activation of Akt in Barrett's oesophagus and oesophageal adenocarcinoma and the functional effects of Akt activation in vitro. METHODS: Expression of total and active (phosphorylated) Akt were determined in endoscopic biopsies and surgical resection specimens using immunohistochemistry. The functional effects of Akt were examined using Barrett's adenocarcinoma cells in culture. RESULTS: In normal squamous oesophagus, erosive oesophagitis and non-dysplastic Barrett's oesophagus, phospho-Akt was limited to the basal 1/3 of the mucosa. Image analysis confirmed that Akt activation was significantly increased in non-dysplastic Barrett's oesophagus compared to squamous epithelium and further significantly increased in high-grade dysplasia and adenocarcinoma. In all cases of high grade dysplasia and adenocarcinoma Akt was activated in the luminal 1/3 of the epithelium. Transient acid exposure and the obesity hormone leptin activated Akt, stimulated proliferation and inhibited apoptosis: the combination of acid and leptin was synergistic. Inhibition of Akt phosphorylation with LY294002 increased apoptosis and blocked the effects of acid and leptin both alone and in combination. Activation of Akt was associated with downstream phosphorylation and deactivation of the pro-apoptotic protein Bad and phosphorylation of the Forkhead family transcription factor FOXO1. CONCLUSION: Akt is abnormally activated in Barrett's oesophagus, high grade dysplasia and adenocarcinoma. Akt activation promotes proliferation and inhibits apoptosis in Barrett's adenocarcinoma cells and both transient acid exposure and leptin stimulate Akt phosphorylation. Downstream targets of Akt include Bad and Forkhead transcription factors. Activation of Akt in obesity and by reflux of gastric acid may be important in the pathogenesis of Barrett's adenocarcinoma Abstract Background The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogenesis. Therefore we have examined the activation of Akt in Barrett's oesophagus and oesophageal adenocarcinoma and the functional effects of Akt activation in vitro. Methods Expression of total and active (phosphorylated) Akt were determined in endoscopic biopsies and surgical resection specimens using immunohistochemistry. The functional effects of Akt were examined using Barrett's adenocarcinoma cells in culture. Results In normal squamous oesophagus, erosive oesophagitis and non-dysplastic Barrett's oesophagus, phospho-Akt was limited to the basal 1/3 of the mucosa. Image analysis confirmed that Akt activation was significantly increased in non-dysplastic Barrett's oesophagus compared to squamous epithelium and further significantly increased in high-grade dysplasia and adenocarcinoma. In all cases of high grade dysplasia and adenocarcinoma Akt was activated in the luminal 1/3 of the epithelium. Transient acid exposure and the obesity hormone leptin activated Akt, stimulated proliferation and inhibited apoptosis: the combination of acid and leptin was synergistic. Inhibition of Akt phosphorylation with LY294002 increased apoptosis and blocked the effects of acid and leptin both alone and in combination. Activation of Akt was associated with downstream phosphorylation and deactivation of the pro-apoptotic protein Bad and phosphorylation of the Forkhead family transcription factor FOXO1. Conclusion Akt is abnormally activated in Barrett's oesophagus, high grade dysplasia and adenocarcinoma. Akt activation promotes proliferation and inhibits apoptosis in Barrett's adenocarcinoma cells and both transient acid exposure and leptin stimulate Akt phosphorylation. Downstream targets of Akt include Bad and Forkhead transcription factors. Activation of Akt in obesity and by reflux of gastric acid may be important in the pathogenesis of Barrett's adenocarcinoma |
ArticleNumber | 97 |
Audience | Academic |
Author | Ogunwobi, Olorunseun El-Amin, Khalid Wilkinson, Mark Cameron, Ewen Beales, Ian L P Mutungi, Gabriel |
AuthorAffiliation | 3 Department of Histopathology, Norfolk and Norwich University Hospital, Norwich, NR4 7UZ, UK 2 Department of Cell Biology and Physiology, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, NR4 7TJ, UK 1 Gastroenterology Unit, Norfolk and Norwich University Hospital, Norwich, NR4 7UZ, UK |
AuthorAffiliation_xml | – name: 3 Department of Histopathology, Norfolk and Norwich University Hospital, Norwich, NR4 7UZ, UK – name: 2 Department of Cell Biology and Physiology, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, NR4 7TJ, UK – name: 1 Gastroenterology Unit, Norfolk and Norwich University Hospital, Norwich, NR4 7UZ, UK |
Author_xml | – sequence: 1 givenname: Ian L P surname: Beales fullname: Beales, Ian L P email: ian.beales@nnuh.nhs.uk organization: Gastroenterology Unit, Norfolk and Norwich University Hospital, Norwich, UK. ian.beales@nnuh.nhs.uk – sequence: 2 givenname: Olorunseun surname: Ogunwobi fullname: Ogunwobi, Olorunseun – sequence: 3 givenname: Ewen surname: Cameron fullname: Cameron, Ewen – sequence: 4 givenname: Khalid surname: El-Amin fullname: El-Amin, Khalid – sequence: 5 givenname: Gabriel surname: Mutungi fullname: Mutungi, Gabriel – sequence: 6 givenname: Mark surname: Wilkinson fullname: Wilkinson, Mark |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17559672$$D View this record in MEDLINE/PubMed |
BookMark | eNp1k0tv1DAQgCNURB9w5YgsIYE4pNh52DEHpKXiUakSEo-zNXHGG5dsnNpOxf5G_hRJt5SNKMohzvibL2N7fJwc9K7HJHnK6CljFX_NCsHSrKAiFakUD5Kju8DB3vgwOQ7hklImKlo9Sg6ZKEvJRXaU_FrpaK8hWtcTZ8jqRyQ2ENtrjxCwmUYktkiabRg6CBZSDV7b3m2ABLwasdc4M-_Ae4zxZSAOgxtaWI-BQN8Q7frobT1GDCS6PfHgXWcN-t2vZ9T2ra3tn0pgcEN0wYY3BEhrQ3QDxNZ1bm01dDcJZuz1jE-fIY7N9nHy0EAX8Mnt-yT5_uH9t7NP6cXnj-dnq4u05kURU1FmRjBGM2QGNGgBOW1MLSrEikvOdJnXVIAxXOYMacV5JaSRgKjrqgSdnyTnO2_j4FIN3m7Ab5UDq24Czq8V-Gh1h0rmWkJdUqhEUzR5AWXJBBclLzTIjPLJ9XbnGsZ6g43GabugW0iXM71t1dpdK1ZJWVI5CVY7QW3dfwTLGe02am4MNTeGEkqKyfF851jDVLPtjZtIvbFBqxXjJecyk9lEnd5DTU-DGzudMxo7xRcJrxYJcy_gz7iGMQR1_vXLkn2xx7YIXWyD68b5fMO9VWjvQvBo7pbKqJqvxL-Le7a_w3_x2zuQ_wazyA10 |
CitedBy_id | crossref_primary_10_1038_s41598_020_69708_2 crossref_primary_10_1111_dote_12210 crossref_primary_10_12659_MSM_898131 crossref_primary_10_1111_j_1572_0241_2007_01773_x crossref_primary_10_18632_oncotarget_8777 crossref_primary_10_1016_j_mce_2008_01_023 crossref_primary_10_1007_s10147_020_01772_0 crossref_primary_10_1007_s10620_011_1899_0 crossref_primary_10_1007_s10620_008_0294_y crossref_primary_10_3892_ol_2015_3260 crossref_primary_10_1038_oby_2009_508 crossref_primary_10_1002_mnfr_200700513 crossref_primary_10_1177_1756283X14538689 crossref_primary_10_1002_ijc_24875 crossref_primary_10_1016_j_mce_2013_08_013 crossref_primary_10_3390_diagnostics12102437 crossref_primary_10_1007_s10620_015_3869_4 crossref_primary_10_1016_j_mce_2008_08_004 crossref_primary_10_4161_cbt_25362 crossref_primary_10_3390_md17100587 crossref_primary_10_1016_j_gtc_2015_03_001 crossref_primary_10_1111_j_1752_8062_2009_00131_x crossref_primary_10_3390_ijms241411318 crossref_primary_10_14814_phy2_13683 crossref_primary_10_1016_j_anndiagpath_2007_12_001 crossref_primary_10_1016_j_jtcvs_2009_09_066 crossref_primary_10_1016_j_semcancer_2017_09_009 crossref_primary_10_1007_s11010_021_04067_8 crossref_primary_10_1111_j_1572_0241_2007_01768_x |
Cites_doi | 10.1056/NEJM199903183401101 10.1016/j.regpep.2005.08.002 10.1136/gut.2004.041558 10.1158/0008-5472.CAN-03-2438 10.1074/jbc.M305063200 10.1016/S0092-8674(00)80595-4 10.1200/JCO.2004.01.103 10.1016/S0092-8674(00)80405-5 10.1074/jbc.M201119200 10.7326/0003-4819-130-11-199906010-00003 10.1016/j.bbrc.2004.08.059 10.3322/canjclin.55.1.10 10.1006/excr.1999.4690 10.1053/gast.2002.30993 10.1152/ajpgi.00167.2005 10.1053/gast.2003.50091 10.1111/j.1572-0241.1999.01276.x 10.1016/j.lfs.2004.03.041 10.1002/bjs.5530 10.1016/S0016-5107(99)70339-1 10.1093/ajcp/103.3.295 10.1152/ajpgi.00144.2004 10.1172/JCI119018 10.1152/ajpgi.00543.2001 10.1038/sj.bjc.6602028 10.1111/j.1572-0241.2002.05767.x 10.1074/jbc.M312999200 10.1136/gut.2004.041566 10.1053/j.gastro.2005.03.077 10.1054/bjoc.2000.1660 10.1016/j.mce.2005.12.050 10.1016/j.jss.2005.03.013 10.1056/NEJM199602013340503 10.1111/j.1572-0241.2002.05768.x 10.1210/en.2006-0224 10.1152/ajpgi.2001.280.2.G298 10.1093/jnci/djg047 10.1038/ncpgasthep0057 10.1152/ajpgi.00215.2005 10.1053/gast.1996.v111.pm8698230 10.1007/s00384-006-0181-y 10.1158/0008-5472.CAN-03-2713 10.1136/gut.52.2.174 10.1016/S0022-4804(03)00166-5 10.1074/jbc.274.24.16741 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2007 BioMed Central Ltd. Copyright © 2007 Beales et al; licensee BioMed Central Ltd. 2007 Beales et al; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2007 BioMed Central Ltd. – notice: Copyright © 2007 Beales et al; licensee BioMed Central Ltd. 2007 Beales et al; licensee BioMed Central Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISR 5PM DOA |
DOI | 10.1186/1471-2407-7-97 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Science PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2407 |
EndPage | 97 |
ExternalDocumentID | oai_doaj_org_article_93c9ab50a87d4d34a551767564ca9206 oai_biomedcentral_com_1471_2407_7_97 A165669292 10_1186_1471_2407_7_97 17559672 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United Kingdom |
GeographicLocations_xml | – name: United Kingdom |
GroupedDBID | --- -A0 0R~ 23N 2VQ 2WC 4.4 53G 5VS 6J9 6PF AAFWJ AAJSJ AAWTL ABDBF ACGFO ACGFS ACIHN ACMJI ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C1A C24 C6C CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P GROUPED_DOAJ GX1 H13 HYE IAO IHR IHW INH INR IPNFZ ISR ITC KQ8 M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A W2D WOQ WOW XSB AAYXX CITATION AFGXO 7X7 ABVAZ AFNRJ 5PM |
ID | FETCH-LOGICAL-b644t-752f71102e1facac7a30dfb78ee86961c53b07aff6931e0866879f9aeecb85ac3 |
IEDL.DBID | RPM |
ISSN | 1471-2407 |
IngestDate | Tue Oct 22 14:38:39 EDT 2024 Tue Sep 17 21:20:31 EDT 2024 Wed May 22 07:11:46 EDT 2024 Fri Feb 23 00:21:15 EST 2024 Wed Nov 13 00:01:31 EST 2024 Sat Sep 28 21:19:12 EDT 2024 Tue Aug 20 22:06:22 EDT 2024 Thu Sep 12 17:47:22 EDT 2024 Sat Sep 28 07:48:17 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b644t-752f71102e1facac7a30dfb78ee86961c53b07aff6931e0866879f9aeecb85ac3 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1899509/ |
PMID | 17559672 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_93c9ab50a87d4d34a551767564ca9206 pubmedcentral_primary_oai_pubmedcentral_nih_gov_1899509 biomedcentral_primary_oai_biomedcentral_com_1471_2407_7_97 gale_infotracmisc_A165669292 gale_infotracacademiconefile_A165669292 gale_incontextgauss_ISR_A165669292 gale_healthsolutions_A165669292 crossref_primary_10_1186_1471_2407_7_97 pubmed_primary_17559672 |
PublicationCentury | 2000 |
PublicationDate | 2007-06-08 |
PublicationDateYYYYMMDD | 2007-06-08 |
PublicationDate_xml | – month: 06 year: 2007 text: 2007-06-08 day: 08 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC cancer |
PublicationTitleAlternate | BMC Cancer |
PublicationYear | 2007 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 10102273 - Cell. 1999 Mar 19;96(6):857-68 16169610 - Regul Pept. 2006 Mar 15;134(1):1-8 10579924 - Exp Cell Res. 1999 Nov 25;253(1):210-29 15887129 - Gastroenterology. 2005 May;128(5):1471-505 12094844 - Am J Gastroenterol. 2002 Jun;97(6):1319-27 12943810 - J Surg Res. 2003 Jul;113(1):50-5 16265072 - Nat Clin Pract Gastroenterol Hepatol. 2004 Dec;1(2):106-12 12612900 - Gastroenterology. 2003 Mar;124(3):615-25 15026323 - Cancer Res. 2004 Mar 15;64(6):1915-9 10445526 - Am J Gastroenterol. 1999 Aug;94(8):2043-53 15964304 - J Surg Res. 2005 Jul 1;127(1):53-8 13130116 - J Natl Cancer Inst. 2003 Sep 17;95(18):1404-13 15483033 - J Clin Oncol. 2004 Oct 15;22(20):4217-26 11259087 - Br J Cancer. 2001 Mar 23;84(6):748-53 15351698 - Biochem Biophys Res Commun. 2004 Oct 8;323(1):44-8 8903332 - J Clin Invest. 1996 Nov 1;98(9):2120-8 10080844 - N Engl J Med. 1999 Mar 18;340(11):825-31 12094845 - Am J Gastroenterol. 2002 Jun;97(6):1328-31 16912864 - Int J Colorectal Dis. 2007 Apr;22(4):401-9 12000750 - J Biol Chem. 2002 Aug 2;277(31):27613-21 14996709 - Cancer Res. 2004 Mar 1;64(5):1561-9 17212381 - Br J Surg. 2007 Mar;94(3):346-54 11832445 - Gastroenterology. 2002 Feb;122(2):299-307 15711005 - Gut. 2005 Mar;54 Suppl 1:i27-32 15661684 - CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30 14752104 - J Biol Chem. 2004 Apr 16;279(16):16495-502 16740977 - Endocrinology. 2006 Sep;147(9):4505-16 15266314 - Br J Cancer. 2004 Aug 16;91(4):714-9 12121879 - Am J Physiol Gastrointest Liver Physiol. 2002 Aug;283(2):G327-34 16239404 - Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G335-42 15474551 - Life Sci. 2004 Nov 5;75(25):2983-95 10375336 - Ann Intern Med. 1999 Jun 1;130(11):883-90 15711004 - Gut. 2005 Mar;54 Suppl 1:i21-6 9346240 - Cell. 1997 Oct 17;91(2):231-41 12826665 - J Biol Chem. 2003 Sep 12;278(37):34783-93 10385717 - Gastrointest Endosc. 1999 Jul;50(1):23-6 12524396 - Gut. 2003 Feb;52(2):174-80 8532024 - N Engl J Med. 1996 Feb 1;334(5):292-5 16081761 - Am J Physiol Gastrointest Liver Physiol. 2005 Dec;289(6):G991-7 10358014 - J Biol Chem. 1999 Jun 11;274(24):16741-6 8698230 - Gastroenterology. 1996 Jul;111(1):85-92 16442704 - Mol Cell Endocrinol. 2006 Mar 9;247(1-2):140-9 15231484 - Am J Physiol Gastrointest Liver Physiol. 2004 Oct;287(4):G743-8 7872251 - Am J Clin Pathol. 1995 Mar;103(3):295-9 11208554 - Am J Physiol Gastrointest Liver Physiol. 2001 Feb;280(2):G298-307 RV Considine (747_CR24) 1996; 334 GH Williams (747_CR38) 2004; 91 BS Kaur (747_CR21) 2002; 283 S Arico (747_CR39) 2002; 277 DT McManus (747_CR9) 2004; 64 ED Tang (747_CR32) 1999; 274 RC Fitzgerald (747_CR3) 2005; 54 MR Hoda (747_CR45) 2007; 94 J Lagergren (747_CR16) 1999; 130 O Ogunwobi (747_CR26) 2006; 147 RF Souza (747_CR23) 2002; 122 JC Harris (747_CR12) 2004; 64 P Somasundar (747_CR27) 2003; 113 JE Thompson (747_CR11) 2004; 22 LS Engel (747_CR19) 2003; 95 D Provenzale (747_CR6) 1999; 94 A Brunet (747_CR31) 1999; 96 IL Beales (747_CR36) 2006; 247 C Tselepis (747_CR15) 2003; 52 K Bodger (747_CR25) 2005; 54 OO Ogunwobi (747_CR35) 2006; 134 MH Kulke (747_CR40) 2001; 84 OO Ogunwobi (747_CR28) 2007; 22 KK Wang (747_CR4) 2005; 128 RF Souza (747_CR41) 2004; 287 KR Geisinger (747_CR37) 1995; 103 P Rouet-Benzineb (747_CR43) 2004; 279 M Alikhan (747_CR5) 1999; 50 IL Beales (747_CR34) 2004; 75 ES Kandel (747_CR10) 1999; 253 K Jaiswal (747_CR42) 2006; 290 A Jemal (747_CR1) 2006; 55 CR Haigh (747_CR13) 2003; 124 L Vona-Davis (747_CR14) 2005; 127 S Ramamoorthy (747_CR46) 2004; 323 CP Caygill (747_CR18) 2002; 97 NJ Shaheen (747_CR8) 2002; 97 JP Spencer (747_CR29) 2003; 278 RC Fitzgerald (747_CR22) 1996; 98 P Sharma (747_CR7) 2005; 54 J Lagergren (747_CR17) 1999; 340 D Armstrong (747_CR33) 1996; 111 GA Sarosi Jr (747_CR20) 2005; 289 SR Datta (747_CR30) 1997; 91 A Todisco (747_CR44) 2001; 280 NS Buttar (747_CR2) 2004; 1 |
References_xml | – volume: 340 start-page: 825 year: 1999 ident: 747_CR17 publication-title: N Engl J Med doi: 10.1056/NEJM199903183401101 contributor: fullname: J Lagergren – volume: 134 start-page: 1 year: 2006 ident: 747_CR35 publication-title: Regul Pept doi: 10.1016/j.regpep.2005.08.002 contributor: fullname: OO Ogunwobi – volume: 54 start-page: i21 issue: Suppl 1 year: 2005 ident: 747_CR3 publication-title: Gut doi: 10.1136/gut.2004.041558 contributor: fullname: RC Fitzgerald – volume: 64 start-page: 1561 year: 2004 ident: 747_CR9 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-2438 contributor: fullname: DT McManus – volume: 278 start-page: 34783 year: 2003 ident: 747_CR29 publication-title: J Biol Chem doi: 10.1074/jbc.M305063200 contributor: fullname: JP Spencer – volume: 96 start-page: 857 year: 1999 ident: 747_CR31 publication-title: Cell doi: 10.1016/S0092-8674(00)80595-4 contributor: fullname: A Brunet – volume: 22 start-page: 4217 year: 2004 ident: 747_CR11 publication-title: J Clin Oncol doi: 10.1200/JCO.2004.01.103 contributor: fullname: JE Thompson – volume: 91 start-page: 231 year: 1997 ident: 747_CR30 publication-title: Cell doi: 10.1016/S0092-8674(00)80405-5 contributor: fullname: SR Datta – volume: 277 start-page: 27613 year: 2002 ident: 747_CR39 publication-title: J Biol Chem doi: 10.1074/jbc.M201119200 contributor: fullname: S Arico – volume: 130 start-page: 883 year: 1999 ident: 747_CR16 publication-title: Ann Intern Med doi: 10.7326/0003-4819-130-11-199906010-00003 contributor: fullname: J Lagergren – volume: 323 start-page: 44 year: 2004 ident: 747_CR46 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2004.08.059 contributor: fullname: S Ramamoorthy – volume: 55 start-page: 10 year: 2006 ident: 747_CR1 publication-title: CA Cancer J Clin doi: 10.3322/canjclin.55.1.10 contributor: fullname: A Jemal – volume: 253 start-page: 210 year: 1999 ident: 747_CR10 publication-title: Exp Cell Res doi: 10.1006/excr.1999.4690 contributor: fullname: ES Kandel – volume: 122 start-page: 299 year: 2002 ident: 747_CR23 publication-title: Gastroenterology doi: 10.1053/gast.2002.30993 contributor: fullname: RF Souza – volume: 290 start-page: G335 year: 2006 ident: 747_CR42 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00167.2005 contributor: fullname: K Jaiswal – volume: 124 start-page: 615 year: 2003 ident: 747_CR13 publication-title: Gastroenterology doi: 10.1053/gast.2003.50091 contributor: fullname: CR Haigh – volume: 94 start-page: 2043 year: 1999 ident: 747_CR6 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1999.01276.x contributor: fullname: D Provenzale – volume: 75 start-page: 2983 year: 2004 ident: 747_CR34 publication-title: Life Sci doi: 10.1016/j.lfs.2004.03.041 contributor: fullname: IL Beales – volume: 94 start-page: 346 year: 2007 ident: 747_CR45 publication-title: Br J Surg doi: 10.1002/bjs.5530 contributor: fullname: MR Hoda – volume: 50 start-page: 23 year: 1999 ident: 747_CR5 publication-title: Gastrointest Endosc doi: 10.1016/S0016-5107(99)70339-1 contributor: fullname: M Alikhan – volume: 103 start-page: 295 year: 1995 ident: 747_CR37 publication-title: Am J Clin Pathol doi: 10.1093/ajcp/103.3.295 contributor: fullname: KR Geisinger – volume: 287 start-page: G743 year: 2004 ident: 747_CR41 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00144.2004 contributor: fullname: RF Souza – volume: 98 start-page: 2120 year: 1996 ident: 747_CR22 publication-title: J Clin Invest doi: 10.1172/JCI119018 contributor: fullname: RC Fitzgerald – volume: 283 start-page: G327 year: 2002 ident: 747_CR21 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00543.2001 contributor: fullname: BS Kaur – volume: 91 start-page: 714 year: 2004 ident: 747_CR38 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602028 contributor: fullname: GH Williams – volume: 97 start-page: 1319 year: 2002 ident: 747_CR8 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2002.05767.x contributor: fullname: NJ Shaheen – volume: 279 start-page: 16495 year: 2004 ident: 747_CR43 publication-title: J Biol Chem doi: 10.1074/jbc.M312999200 contributor: fullname: P Rouet-Benzineb – volume: 54 start-page: i27 issue: Suppl 1 year: 2005 ident: 747_CR7 publication-title: Gut doi: 10.1136/gut.2004.041566 contributor: fullname: P Sharma – volume: 128 start-page: 1471 year: 2005 ident: 747_CR4 publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.03.077 contributor: fullname: KK Wang – volume: 84 start-page: 748 year: 2001 ident: 747_CR40 publication-title: Br J Cancer doi: 10.1054/bjoc.2000.1660 contributor: fullname: MH Kulke – volume: 247 start-page: 140 year: 2006 ident: 747_CR36 publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2005.12.050 contributor: fullname: IL Beales – volume: 127 start-page: 53 year: 2005 ident: 747_CR14 publication-title: J Surg Res doi: 10.1016/j.jss.2005.03.013 contributor: fullname: L Vona-Davis – volume: 334 start-page: 292 year: 1996 ident: 747_CR24 publication-title: N Engl J Med doi: 10.1056/NEJM199602013340503 contributor: fullname: RV Considine – volume: 97 start-page: 1328 year: 2002 ident: 747_CR18 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2002.05768.x contributor: fullname: CP Caygill – volume: 147 start-page: 4505 year: 2006 ident: 747_CR26 publication-title: Endocrinology doi: 10.1210/en.2006-0224 contributor: fullname: O Ogunwobi – volume: 280 start-page: G298 year: 2001 ident: 747_CR44 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.2001.280.2.G298 contributor: fullname: A Todisco – volume: 95 start-page: 1404 year: 2003 ident: 747_CR19 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djg047 contributor: fullname: LS Engel – volume: 54 start-page: A70 issue: Suppl VII year: 2005 ident: 747_CR25 publication-title: Gut contributor: fullname: K Bodger – volume: 1 start-page: 106 year: 2004 ident: 747_CR2 publication-title: Nat Clin Pract Gastroenterol Hepatol doi: 10.1038/ncpgasthep0057 contributor: fullname: NS Buttar – volume: 289 start-page: G991 year: 2005 ident: 747_CR20 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00215.2005 contributor: fullname: GA Sarosi Jr – volume: 111 start-page: 85 year: 1996 ident: 747_CR33 publication-title: Gastroenterology doi: 10.1053/gast.1996.v111.pm8698230 contributor: fullname: D Armstrong – volume: 22 start-page: 401 year: 2007 ident: 747_CR28 publication-title: Int J Colorectal Dis doi: 10.1007/s00384-006-0181-y contributor: fullname: OO Ogunwobi – volume: 64 start-page: 1915 year: 2004 ident: 747_CR12 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-2713 contributor: fullname: JC Harris – volume: 52 start-page: 174 year: 2003 ident: 747_CR15 publication-title: Gut doi: 10.1136/gut.52.2.174 contributor: fullname: C Tselepis – volume: 113 start-page: 50 year: 2003 ident: 747_CR27 publication-title: J Surg Res doi: 10.1016/S0022-4804(03)00166-5 contributor: fullname: P Somasundar – volume: 274 start-page: 16741 year: 1999 ident: 747_CR32 publication-title: J Biol Chem doi: 10.1074/jbc.274.24.16741 contributor: fullname: ED Tang |
SSID | ssj0017808 |
Score | 2.0719628 |
Snippet | The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been... BACKGROUND: The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene... Abstract Background The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and... |
SourceID | doaj pubmedcentral biomedcentral gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 97 |
SubjectTerms | Adenocarcinoma - enzymology Adenocarcinoma - pathology Apoptosis Barrett Esophagus - enzymology Barrett Esophagus - pathology Barrett's esophagus Cancer Carcinoma Cell Proliferation Cell Transformation, Neoplastic - metabolism Dysplasia Enzyme Activation - physiology Esophageal Neoplasms - enzymology Esophageal Neoplasms - pathology Genetic aspects Humans Image Processing, Computer-Assisted Immunohistochemistry Physiological aspects Precancerous Conditions - enzymology Precancerous Conditions - pathology Protein kinases Proto-Oncogene Proteins c-akt - metabolism |
SummonAdditionalLinks | – databaseName: BiomedCentral dbid: RBZ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSIgL4s1CAQsh7SkiTz9620VUBakcgEoVF8tx7DYqJBHJHviN_ClmnEfr9shtFY-jdWZsf-MZf0PIu1hUrjCA3KRMXYSBs0gLZyJRVLzIHcu4rxl5_IUdneSfT4vTy_OOaxH8RLD3CSyfGAPgEY8kv03upEiogn759scSL-DC155bZCd6xpv9r91r_xlsR561f1mblx0pzJa8sv0cPiD3J9xIN6OiH5JbtnlE7h5PkfHH5O_GzIXKaOvo5mKgdU_rBkFhbyv4RQHq0epP3_mLk5HBIkJN-0vTOZsaZbZj5u66p63FAgf6bNdT3VTUp7RjbSzb06G98uIOy_44OxqSF62b87qs53-iu7Yb2r7uD6imnt0YiyDPS67vgHvreCRJPdvtE3Jy-PH7h6NoKtQQlQCnhogXqeOAI1KbOG204TqLK1dyYa1gkiWmyMqYa-eYzBILThQTXDqprTWlKLTJnpK9pm3sc0KToooriScypcgdoAmewW6iMfxZWl3oFTkI9Ke6kZRDIU122AIzVqHyFSpfcSX5iqxnZS_9vBMk2A3JLdpC8Hb_ACxTTXNaycxIXRaxFrzKqyzXgD6RG4flRsMQ2Iq8QUtS443WZSlRG2Q8YoBL0xV56yWQiKPBTJ8zvet79enb10BoPQm5FgYG33e8OAEfDLm7Asn9QBJWChM0Pxst-XLwHBxKxqGFBzYejDtsaepzT0KegKMOYPPF_-jjJbk3p1_GYp_sDb939hVgvKF87af3P424UtA priority: 500 providerName: BioMedCentral – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojwXClgIaU9Rk0386m2LqApSOQCVerMcx24jIIlI9tDfyJ9ixnmwFgcu3KJ4EsX2ZB72-PsIeZvKyjMLkZtSG5_gxllipLeJZJVghee5CJyRF5_4-WXx8Ypd7VF9YU3YCA88Dtyxyq0yJUuNFFVR5YUBF48AJLywRm0msO1UzcnUtH8gZOCiy8D04v6BmOAaM8mPl3uJSBDqKTrn_j1yTwHFf7HVi4eKqyf33NHZA3J_iiPpdvz-Q3LHNQ_J3Ytpp_wR-bW1M3EZbT3dfhto3dO6wSCxdxVcUQj9aHXbd-EgZWKRVKhpfxg6V1ejzOlYybvuaeuQ8MBc73pqmoqGEnfkynI9Hdq9F3dIA-TdqFhBtG5u6rKev8R0bTe0fd2fUEMD2jGSIs8mODyAvnZcoqQB_fYxuTx7__XdeTIRNyQlhFdDItjGC4grNi7zxhorTJ5WvhTSOckVzyzLy1QY77nKMwdJFZdCeWWcs6VkxuZPyEHTNu4ZoRmr0krhCk0pCw_RhcjBuxjcDi2dYWZFTqL5090I0qERNjtugT9Y4-RrnHwttBIrsp4ne3kuJEWS_yV5iroQvT3cAFXVk6rqf6nqirxGTdLjCdfFtOgtIiBxiFM3K_ImSCAwR4OVP9dm1_f6w5fPkdB6EvItdAzGdzxIAQOGWF6R5FEkCZbDRs1PR03-03kBCSYX0CIiHY_6Hbc09U0AJc8gcYfg8_n_GKgX5N5clpnKI3Iw_Ny5lxD7DeWr8Jv_BmYNWeI priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZgSIgXxG8KAyyE1KdA0iS2MwmhDjENpPEAVNqb5Th2FzGSUqcS-xv5p7hzknZmPPJWxeeotu_s73Ln7wh5FYvK5hqQW1HMbISBs0gJqyORVzzPLEu5rxl58pkdL7JPp_npLv9pmED3T9cO60kt1uevf_28eAcG_9YbvGBvEthgMUrAIx4V_Dq5McvAS8c0vmwXUeDCV6fbyg4Ejlf7_3Xz_Tw4sDyv_3b33p5ZYT7lpQPq6A65PSBLOu9V4S65Zpp75ObJEDu_T37P9VjKjLaWzr93tHa0bhA2OlPBLwpgkFYXbuWvVkYayww17Q9Fx3xrlDnsc3unjrYGSyCo5cZR1VTUJ71j9SzjaNdeevEKCwNZ06uaF62bs7qsx3-iVu2qa13tDqiinv8YyySPm7LvgKdv_9GSej7cB2Rx9OHb--NoKOUQlQC4uojnM8sBacxMYpVWmqs0rmzJhTGCFSzReVrGXFnLijQx4GYxwQtbKGN0KXKl04dkr2kb85jQJK_iqsBvNqXILOANnsJ5ozBAWhqVqwk5CNZPrnraDolE2mEL2LTExZe4-JLLgk_IdFzsbT_vJgl2RfIQdSF4u3_QrpdysHpZpLpQZR4rwausSjMF-BTZc1imFQyBTcgL1CTZ33ndbjZyjpxIDJDrbEJeegmk6mgwF2ipNs7Jj1-_BELTQci2MDCY3_5qBUwYsnsFkvuBJOwlOmh-1GvybvAcXE7GoYUHOh6MO2xp6jNPU56AKw9w9Mn_mKin5NaYqBmLfbLXrTfmGaDBrnzuzfwP5P5hBw priority: 102 providerName: Scholars Portal |
Title | Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17559672 http://dx.doi.org/10.1186/1471-2407-7-97 https://pubmed.ncbi.nlm.nih.gov/PMC1899509 https://doaj.org/article/93c9ab50a87d4d34a551767564ca9206 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHhAXxJuFUiyEtKd0k03iR2-7FVVBWoQKlSoukePY24huEjXZQ39j_xQzTrLU4sYlWq3HUZzM47M9_oaQT6EobKoBuUk5twFunAVKWB2ItOBpYlnMXc3I1Td2fpl8vUqv9kg6noVxSfs6L4-rm81xVV673Mpmo2djntjs--o0gkkCBLrZPtkHBR2n6MPWARehGNgZI8FmEXhf3ELgAQ-kK7nHAUQzZAT2TrjfeIHJ8ffvvPQuNvl5kw8C0dlT8mRAkHTRP-kzsmeq5-TRatgjf0HuF3osWUZrSxe_O1q2tKwQHramgF8UQB8t7trGHaEMNJYTquqNomNeNcos-xzeaUtrg6UO1HrbUlUV1CW3Y5Us09KufnDjBgsAWdOrlBMtq-syL8cnUU3ddHVbtidUUcdzjOWQR-frOmCU7RcnqeO9fUkuzz7_PD0PhpINQQ7Aqgt4OrccEMXcRFZppbmKw8LmXBgjmGSRTuM85MpaJuPIwHSKCS6tVMboXKRKx6_IQVVX5g2hUVqEhcS1mVwkFnAFjyGuKNwIzY1K1YSceN8va3p6jgwJs_0WsN0M9SBDPch4JvmETMePvevnpkOC_SO5RF3w7u7-qG_X2aCUmYy1VHkaKsGLpIgTBTgUWXJYohUMgU3IB9SkrD_bunMq2QK5jxgg1PmEfHQSSMlRYc7PWm3bNvvy48ITmg5CtoaBwfvtj1DAC0MWL0_y0JMEn6G95te9Jv8d_GAVE8I9HffG7beAdTo68sEa3_53z3fk8ZiFGYpDctDdbs17gHpdfuSWSOC6SgRcL5a_jpyx_wF75Vx1 |
link.rule.ids | 108,230,315,730,783,787,867,888,2109,2228,24330,24949,27936,27937,53804,53806,76140,76141 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbGkIAXxM9RGMxCSH3KmjSJ7eytm5g6WCcEm7Q3y3HsLmJNqiV94G_kn-LOScos3nir6nMUJ3e-z7m77wj5FIrCphqQW5ZNbYCBs0AJqwORFjxNLIu56xm5uGDzq-TLdXq9Q9KhFsYl7eu8PKxuV4dVeeNyK9crPRnyxCbfFicRHBLA0U0ekIdgr2EyHNL74AEXoej5GSPBJhHsvxhE4AEPMtd0jwOMZsgJ7NW433quyTH4b_fprXfyMyfvuaLTZ-RpjyHprLvX52THVC_Io0UfJX9Jfs_00LSM1pbOfra0bGhZIUBsTAG_KMA-Wvxq1q6IMtDYUKiqV4oOmdUoc9xl8Y4bWhtsdqCWm4aqqqAuvR37ZJmGtvW9C6-xBZA1nVI50bK6KfNyuBO1rtdt3ZTNEVXUMR1jQ-Rh-3UT0M92nyepY759Ra5OP1-ezIO-aUOQA7RqA55OLQdMMTWRVVppruKwsDkXxgiWsUincR5yZS3L4sjAgYoJntlMGaNzkSodvya7VV2ZN4RGaREWGX6dyUViAVnwGDyLwlBoblSqRuTIe39y3RF0SKTM9kfAeiXqgUQ9kFxmfETGw8veznMHIsH-kTxGXfCu7v6o75ayV0uZxTpTeRoqwYukiBMFSBR5cliiFSyBjcgBapLsqlu324qcIfsRA4w6HZGPTgJJOSrM-lmqTdPIsx_fPaFxL2RrWBg8366IAh4Y8nh5kvueJOwa2hve6zT57-J7qxgR7um4t25_BOzTEZL39vj2v2cekMfzy8W5PD-7-PqOPBlyMkOxT3bbu415D8CvzT84M_8DUmtc7Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdgSBMXxDeFwSyE1FPWpGlsZ7duUG1ApwmYtJvlOHYXsSbRkh74G_mneM9JSi1u3Kr6OYqT9_Fz3vPvEfIhFLlNNCC3NJ3aABNngRJWByLJeTKzLOauZ-Tygp1dzT5fJ9c7rb5c0b7OiqPydn1UFjeutrJe68lQJza5XJ5GsEmAQDepczu5Tx6AzYZs2Kj3CQQuQtFzNEaCTSLwwZhI4AEPUtd4jwOUZsgL7J1zv_XCk2Px3_rqbYTyqyd3wtHiMXnU40g67-73Cblnyqdkf9lnyp-R33M9NC6jlaXzny0tGlqUCBIbk8MvCtCP5r-a2h2kDDQ2FSqrtaJDdTXKnHSVvOOGVgYbHqjVpqGqzKkrccdeWaahbbVz4RrbAFnTKZYTLcqbIiuGO1F1VbdVUzTHVFHHdoxNkQcX7CZgrO0-UVLHfvucXC0-_Tg9C_rGDUEG8KoNeDK1HHDF1ERWaaW5isPcZlwYI1jKIp3EWciVtSyNIwObKiZ4alNljM5EonT8guyVVWleERoleZin-IUmEzML6ILHEF0UpkMzoxI1Isfe-5N1R9IhkTbbHwELlqgHEvVAcpnyERkPL3s7z22KBPtH8gR1wbu6-6O6W8leNWUa61RlSagEz2d5PFOARpErh820giWwETlETZLdCdeta5FzZEBigFOnI_LeSSAxR4mVPyu1aRp5_v2bJzTuhWwFC4Pn2x2kgAeGXF6e5IEnCZ5De8MvO03-u_jeKkaEezrurdsfARt1pOS9Tb7-75mHZP_y40J-Pb_48oY8HMoyQ3FA9tq7jXkL2K_N3jkr_wMZAF4A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activation+of+Akt+is+increased+in+the+dysplasia-carcinoma+sequence+in+Barrett%27s+oesophagus+and+contributes+to+increased+proliferation+and+inhibition+of+apoptosis%3A+a+histopathological+and+functional+study&rft.jtitle=BMC+cancer&rft.au=El-Amin+Khalid&rft.au=Cameron+Ewen&rft.au=Ogunwobi+Olorunseun&rft.au=Beales+Ian+LP&rft.date=2007-06-08&rft.pub=BMC&rft.issn=1471-2407&rft.eissn=1471-2407&rft.volume=7&rft.issue=1&rft.spage=97&rft_id=info:doi/10.1186%2F1471-2407-7-97&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_93c9ab50a87d4d34a551767564ca9206 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |